Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Bundang Gu
Clinical trial register · South Korea

Clinical Trials in Bundang Gu, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3427 matching records held by the registry are in this view. Synced 20 Nov 2026, 03:17 UTC
3427
Studies in scope
all four open statuses
1884
Recruiting now
open to new participants
516
Lead sponsors
across recruiting studies
Top sites
Seoul 2883 Daegu 557 Seongnam-si 491 Busan 472 Goyang-si 403
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Bundang Gu

11 of 3427 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
Novartis Pharmaceuticals
Phase 3
570
Bundang Gu, Suwon, Gwangju, Seoul
2026-07-16
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Daegu, Wŏnju, Bundang Gu, Suwon, Incheon, Seoul, Busan, Gwangju
2026-05-11
Recruiting
Long-term Follow up Local Registry Study of Kymriah in South Korea
NCT06785818B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Novartis Pharmaceuticals
Observational
500
Bundang Gu, Seongnam-si, Gyeonggi-do, Incheon, Seoul, Busan, Jeollanam, Ulsan
2025-03-12
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Bundang Gu, Gyeonggi-do, Seoul, Incheon, Seongnam Gyeonggi
2024-02-28
Active, closed
Novartis Pharmaceuticals
Observational
683
Daegu, Wŏnju, Bucheon-si, Bundang Gu, Goyang-si, Yangsan, Jeonju, Suncheon
2022-05-09
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Daegu, Wŏnju, Bundang Gu, Jinju, Yangsan, Seoul, Cheongju-si, Busan
2021-11-23
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Bundang Gu, Seoul, Cheongju-si, Busan, Taegu
2021-09-20
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Seoul, Wŏnju, Bundang Gu, Suwon, Gyeonggi-do, Cheongju-si, Incheon, Seongnam Gyeonggi
2018-12-07
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/bundang-gu

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,427 studies in total at the last sync on 20 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies with a site in Bundang Gu.

How many clinical trials are recruiting in Bundang Gu?

3 of the 11 studies on this page are recruiting new participants as of the 20 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bundang Gu), 11 studies
PhaseStudiesRecruitingShare
Phase 38272.7%
Observational2118.2%
Phase 4109.1%

Most active sponsors

Lead sponsors with the most studies (Bundang Gu)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals103
Bayer10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.